CM Life Sciences III said its shares of Class A common stock and redeemable warrants may be traded separately starting May 28.
Shares and warrants that are separated will trade on the Nasdaq under CMLT and CMLTW, respectively. Units not separated will continue to trade on Nasdaq under the symbol CMLTU.
CM Life Sciences III raised $552 million in an IPO last month. This is the latest SPAC launched by CEO Eli Casdin, founder of Casdin Capital, an investment firm focused on the life sciences and healthcare industry. Read more.
